The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Ventyx Biosciences Inc shares valued at $49,841 were sold by Nuss John on Dec 27 ’24. At $2.36 per share, Nuss John sold 21,119 shares. The insider’s holdings dropped to 464,582 shares worth approximately $1.05 million following the completion of this transaction.
Also, Nuss John purchased 21,119 shares, netting a total of over 49,842 in proceeds.
Before that, Gujrathi Sheila had added 130,000 shares to its account. In a trade valued at $300,573, the Director bought Ventyx Biosciences Inc shares for $2.31 each. Upon closing the transaction, the insider’s holdings increased to 130,000 shares, worth approximately $0.29 million.
As published in a research note from Wells Fargo on March 12, 2024, Ventyx Biosciences Inc [VTYX] has been rated up from an Equal weight to an Overweight and the price target has been revised to $16 from $7. Analysts at Oppenheimer upgraded the stock from ‘”a Perform”‘ to ‘”an Outperform”‘ outlook in a report released in mid March. As of November 07, 2023, Wells Fargo has decreased its “an Overweight” rating to a “an Equal weight” for VTYX. Earlier on November 07, 2023, Stifel downgraded its rating. Their new recommendation was “a Hold” for VTYX stock which previously was a “a Buy”.
Analyzing VTYX Stock Performance
During the last five days, there has been a surge of approximately 2.74%. Over the course of the year, Ventyx Biosciences Inc shares have jumped approximately 2.74%. Shares of the company reached a 52-week high of $2.61 on 01/07/25 and a 52-week low of $2.12 on 01/02/25. A 50-day SMA is recorded $2.29, while a 200-day SMA reached $2.95. Nevertheless, trading volume fell to 5.4 million shares from 1.28 million shares the previous day.
Support And Resistance Levels for Ventyx Biosciences Inc (VTYX)
According to the 24-hour chart, there is a support level at 2.16, which, if violated, would cause prices to drop to 2.06. In the upper region, resistance lies at 2.43. The next price resistance is at 2.60. RSI (Relative Strength Index) is 47.04 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.08, which suggests the price will decrease in the coming days. Percent R is at 69.61%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
